Influence of Rivastigmine transdermal on butyrylcholinesterase levels in patients with Alzheimer's disease

Cholinesterase inhibitors (ChE-Is) are among the main drugs approved for the treatment of Alzheimer's disease (AD). Rivastigmine in the form of a transdermal patch is an alternative delivery method, and can give greater treatment compliance. OBJECTIVES: To conduct a preliminary assessment of th...

Descripción completa

Detalles Bibliográficos
Autores principales: dos Santos, Gustavo Alves Andrade, Canineu, Paulo Renato, Gonçalves, Ivair Donizette, Pardi, Paulo Celso
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Associação de Neurologia Cognitiva e do Comportamento 2011
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5619047/
https://www.ncbi.nlm.nih.gov/pubmed/29213761
http://dx.doi.org/10.1590/S1980-57642011DN05040012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5619047/
https://www.ncbi.nlm.nih.gov/pubmed/29213761
http://dx.doi.org/10.1590/S1980-57642011DN05040012

Ejemplares similares